Keywords:
Diclofenac sodium; eudragit EPO; fatty acid; lauric acid; myristic acid; palmitic acid; pediatric formulation; polyelectrolyte complex; stearic acid; taste masking
Abstract:
Paediatric patients continue to lack access to age-appropriate oral medicines for their treatment and have to depend on the off-label use of medicines approved for adults, which compromises dosing accuracy and exposes children to unpleasant bitterness.